Showing results (251-260 of 601) with videos related to

Sort By:
Pageof 61
Lupus Science & Medicine|August 22, 2023
Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in ChinaYangzhong Zhou, Chaojun Hu, Wanting Qi, et al.
CNS Neuroscience & Therapeutics|May 4, 2024
Identification of the circRNA-miRNA-mRNA network for treating methamphetamine-induced relapse and behavioral sensitization with cannabidiolLiu Liu, Chan Wang, Haowei Wang, et al.
Angewandte Chemie (International Ed. in English)|May 27, 2026
An Electron Relay Driven by Built-in Electric Fields for Self-Sustaining and External-Energy-Free Fenton-Like CatalysisXiaofeng Zeng, Caihua Liu, Junhui Zhou, et al.
Psychopharmacology|January 8, 2022
Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathwayBaoyu Shen, Dongxian Zhang, Xiaofeng Zeng, et al.
Frontiers in Immunology|July 14, 2022
Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese CohortSuying Liu, Linna Han, Yanhui Liu, et al.
International Journal of Rheumatic Diseases|May 31, 2017
Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trialQingjun Wu, Jie Chang, Hua Chen, et al.
Biochemical and Biophysical Research Communications|January 24, 2012
Novel systemic lupus erythematosus autoantigens identified by human protein microarray technologyWei Huang, Chaojun Hu, Haipan Zeng, et al.
Arthritis Research & Therapy|December 21, 2019
High-throughput sequencing of CD4+ T cell repertoire reveals disease-specific signatures in IgG4-related diseaseLiwen Wang, Panpan Zhang, Jieqiong Li, et al.
Plos One|June 19, 2013
Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunctionXinjuan Liu, Na Gao, Mengtao Li, et al.
Scientific Reports|August 10, 2017
Anti-SmD1 antibodies are associated with renal disorder, seizures, and pulmonary arterial hypertension in Chinese patients with active SLEChaojun Hu, Mengtao Li, Jian Liu, et al.
Pageof 61